Quote | Renalytix AI plc (NASDAQ:RNLX)
Last: | $0.294 |
---|---|
Change Percent: | 2.09% |
Open: | $0.3 |
Close: | $0.294 |
High: | $0.3062 |
Low: | $0.2903 |
Volume: | 279,034 |
Last Trade Date Time: | 07/24/2024 03:00:00 am |
News | Renalytix AI plc (NASDAQ:RNLX)
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...
Message Board Posts | Renalytix AI plc (NASDAQ:RNLX)
Subject | By | Source | When |
---|---|---|---|
Price gaining up | Moeclay | investorshub | 06/26/2023 4:13:12 PM |
$RNLX short squeeze article | Moeclay | investorshub | 06/19/2023 8:13:25 PM |
$RNLX Good news recently, we should start to see this one move | Moeclay | investorshub | 06/10/2023 7:17:06 PM |
short squeeze article | Moeclay | investorshub | 06/08/2023 10:54:56 AM |
Have a look at this | wwind | investorshub | 06/08/2023 7:25:02 AM |
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...
LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces ...